Apollomics to participate in a fireside chat at the b. riley securities' 2024 virtual oncology conference

Foster city, calif., jan. 17, 2024 (globe newswire) -- apollomics inc. (“apollomics” or the “company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that guo-liang yu, ph.d., chairman and chief executive officer of apollomics, and sanjeev redkar, ph.d., president of apollomics, will participate in a fireside chat at the b. riley securities 2024 virtual oncology conference on thursday, january 18, 2024 at 11:00 a.m. et.
APLM Ratings Summary
APLM Quant Ranking